BRIEF-Medicinova says FDA granted orphan drug designation to MN-166 for ALS
October 11, 2016 at 19:06 PM EDT
* Medicinova announces FDA granted orphan drug designation to MN-166 (ibudilast) for amyotrophic lateral sclerosis
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.